📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-14 20:10
0 analysed today
0
Today
133,620
All-time analysed
40,132
Positive
6,284
Negative
79,384
Neutral
7,752
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
16 announcements match the current filters (relevance ≥ 5).
Q1 Revenue Up 155% YoY to ₹41.48 Cr, Net Profit Falls 49% to ₹0.16 Cr
Ishan Dyes and Chemicals reported a 154.7% YoY increase in revenue from operations to ₹41.48 cr (₹4,148.04 lakhs) for the quarter ended June 30, 2026, compared to ₹16.29 cr in the previous year. However, net profit declined 49.0% YoY to ₹0.16 cr (₹15.50 lakhs) from ₹0.30 cr, heavily compressed by higher raw material costs, finance costs (₹2.50 cr vs ₹1.26 cr YoY), and depreciation (₹2.05 cr vs ₹0.61 cr YoY). On a sequential basis, net profit fell 89.4% from ₹1.46 cr in the preceding March 2026 quarter. Additionally, statutory auditors issued a qualified conclusion on the standalone financial results.
Confidence: HIGH
What changedIshan Dyes reported standalone Q1 FY27 results featuring substantial top-line growth but sharp margin contraction and an auditor qualified conclusion.
Why it mattersSignificant top-line revenue expansion indicates product ramp-up, but higher raw material consumption, interest, and depreciation expenses have squeezed bottom-line profitability to near breakeven.
Revenue from Operations (Q1): ₹4148.04 LakhsNet Profit (Q1): ₹15.50 LakhsCost of Materials Consumed: ₹3058.80 LakhsFinance Costs: ₹249.82 LakhsDepreciation Expense: ₹204.51 LakhsBasic EPS: ₹0.06
📅 Short termNear-term sentiment may be muted due to sharp net margin contraction and the presence of an auditor qualification.
📈 Long termStructural value creation depends on the company stabilizing input cost volatilities and generating sufficient operating cash flows to offset elevated financing and depreciation costs.
⚠ Risk flags
- Qualified conclusion expressed by statutory auditors
- Severe operating margin compression
- Elevated finance and depreciation charges
Key Highlights
Revenue from operations rose 154.7% YoY to ₹4,148.04 lakhs compared to ₹1,628.83 lakhs in Q1 FY26
Net profit declined 49.0% YoY and 89.4% QoQ to ₹15.50 lakhs from ₹30.40 lakhs in Q1 FY26 and ₹146.49 lakhs in Q4 FY26
Finance costs increased to ₹249.82 lakhs (up from ₹126.33 lakhs YoY) and depreciation rose to ₹204.51 lakhs (up from ₹60.50 lakhs YoY)
Statutory auditors M/s A R Sulakhe & Co issued a Qualified Conclusion on the un-audited standalone results
33rd Annual General Meeting scheduled for Tuesday, September 29, 2026
👀 What to Watch
Review the specific nature of the auditor's qualified conclusion in the limited review report and watch for margin recovery and cost absorption as expanded capacities scale up.
4 New Sulphur-Based Products to Launch Within 3 Months at Sulphuric Acid Unit
Ishan Dyes and Chemicals has commenced work on four new high-value sulphur-based products at its Sulphuric Acid Unit. These products are expected to be commercially launched by October 2026, following a three-month development and ramp-up period. This initiative is part of a broader strategy to diversify into specialty chemicals, complementing the company's ongoing ₹70.97 Cr investment in a bulk chemical intermediates plant. The move is intended to enhance margins and strengthen market presence amidst a competitive global environment.
Confidence: HIGH
What changedThe company is expanding its product portfolio from basic chemicals and dyes into four specific high-value downstream sulphur-based products.
Why it mattersThis shift towards high-value products is critical for improving profitability and reducing vulnerability to commodity price cycles and intense competition in the basic dyes segment.
New products added: 4Launch timeline: 3 monthsOngoing project investment: ₹70.97 CrHistorical export turnover: ₹41.30 Cr
📅 Short termPositive sentiment is expected as the company moves toward commercializing new products within a short 90-day window.
📈 Long termRepresents a structural move toward becoming a more diversified specialty chemicals player, potentially re-rating the business if margin expansion is sustained.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Operational ramp-up risks
- Market acceptance of new products
- Global recessionary trends impacting export demand
Key Highlights
Commencement of work for 4 new high-value sulphur-based products
Commercial launch targeted within the next 3 months (by October 2026)
Expansion leverages the existing Sulphuric Acid Unit for value-added production
Complements the existing ₹70.97 Cr investment in a new bulk chemical intermediates plant
Aims to mitigate pricing pressures from Chinese exports and global volatility
👀 What to Watch
Investors should monitor the successful commercialization of these products by October 2026 and track subsequent quarterly results for improvements in operating margins.
Ishan Dyes Proposes Exclusive Dealership with A-1 Ltd; Supplied ₹40 Cr Since Feb 2026
Ishan Dyes and Chemicals has formally proposed an exclusive dealership arrangement to A-1 Limited, a listed public company, for seven sulphur-based industrial products. The company has already established a significant relationship with A-1 Limited, supplying materials worth approximately ₹40 Crores between February 2026 and July 2026. If finalized, the arrangement is expected to enhance revenue visibility and market share, complementing the company's ongoing ₹70.97 Cr investment in a new bulk chemical intermediates plant. Currently, the proposal remains non-binding with no definitive agreement executed yet.
Confidence: HIGH
What changedThe company has moved from a standard supplier relationship to proposing a formal exclusive dealership model with a major listed client.
Why it mattersSecuring an exclusive dealership could provide a stable, high-volume sales channel for sulphur-based products, supporting the company's broader expansion into bulk chemical intermediates.
Existing supply to A-1 Ltd: ₹40 CroresNew plant investment: ₹70.97 CroresHistorical export turnover: ₹41.30 CroresSupply since Feb 2026 vs Export Turnover: ~97%
📅 Short termThe stock may see speculative interest based on the potential for a large exclusive contract, though the non-binding nature of the proposal suggests caution.
📈 Long termIf finalized, this dealership could significantly stabilize revenue and improve margins through scale, aligning with the 2025 capacity expansion goals.
⚠ Risk flags
- Non-binding proposal
- Client concentration risk
- Execution risk of the new ₹70.97 Cr plant
Key Highlights
Supplied materials worth ~₹40 Crores to A-1 Limited in the five-month period since February 2026
Proposal covers 7 products including Sulphuric Acid (98% & 70%), Oleum (23% & 65%), and Chloro Sulphonic Acid
Company is currently investing ₹70.97 Cr in a new plant for bulk chemical intermediates expected by late 2025
The proposal aims to leverage an existing distribution network and established customer base for incremental growth
👀 What to Watch
Monitor for a follow-up announcement confirming the acceptance of the proposal and the signing of a binding agreement with A-1 Limited.
Ishan Dyes Reports FY26 Net Loss of ₹7.11 Cr; Q4 Shows Recovery with ₹1.46 Cr Profit
Ishan Dyes and Chemicals reported a weak performance for FY26, with annual revenue from operations declining 27.6% to ₹73.47 crore from ₹101.47 crore in FY25. The company swung to a net loss of ₹7.11 crore for the full year, compared to a profit of ₹1.08 crore in the previous fiscal. However, Q4 FY26 provided some relief with a net profit of ₹1.46 crore, a significant recovery from the ₹5.25 crore loss reported in Q3 FY26. The company also announced the appointment of M/s. H D Panchal & Co. as Internal Auditors for FY27.
Key Highlights
Annual revenue from operations fell 27.6% YoY to ₹73.47 crore in FY26.
Reported a net loss of ₹7.11 crore for FY26 against a profit of ₹1.08 crore in FY25.
Q4 FY26 revenue stood at ₹31.75 crore, showing a sequential recovery from ₹18.69 crore in Q3.
Finance costs rose to ₹7.02 crore in FY26 from ₹5.13 crore in FY25.
Full-year Basic EPS declined to -₹3.00 from ₹0.52 in the previous year.
👀 What to Watch
Investors should remain cautious as the company has moved into a full-year loss despite a slight recovery in the final quarter. Monitor the sustainability of the Q4 margin improvement and revenue growth before considering long-term positions.
Ishan Dyes Reports FY26 Net Loss of ₹7.11 Cr; Auditors Issue Qualified Opinion
Ishan Dyes and Chemicals Limited reported a significant annual downturn for FY26, swinging to a net loss of ₹710.85 lakhs from a profit of ₹108.50 lakhs in FY25. Annual revenue from operations fell by approximately 27.6% to ₹7,347.13 lakhs. While Q4 FY26 showed a recovery with a net profit of ₹146.49 lakhs, the statutory auditors have issued a 'Qualified Opinion' on the financial results, necessitating a revised filing to include the Statement of Impact of Audit Qualifications.
Key Highlights
Company reported a net loss of ₹710.85 lakhs for FY26 compared to a profit of ₹108.50 lakhs in FY25.
Annual revenue from operations declined to ₹7,347.13 lakhs from ₹10,146.96 lakhs in the previous year.
Statutory Auditors M/s A R Sulakhe & Co issued a Qualified Opinion on the audited financial results.
Q4 FY26 standalone net profit stood at ₹146.49 lakhs, a turnaround from a loss of ₹116.20 lakhs in Q4 FY25.
Board appointed M/s. H D Panchal & Co. as Internal Auditors for the financial year ending March 31, 2027.
👀 What to Watch
Investors should remain cautious as the shift from profit to a substantial annual loss combined with an audit qualification are significant red flags. It is essential to review the specific details of the audit qualifications to understand the underlying accounting or operational risks.
Ishan Dyes Q4 Net Profit at ₹1.46 Cr; FY26 Revenue Drops 27.6% YoY
Ishan Dyes and Chemicals reported a quarterly turnaround with a net profit of ₹146.49 lakhs in Q4 FY26, compared to a loss of ₹116.20 lakhs in the same period last year. However, the full-year performance for FY26 remained under pressure, posting a net loss of ₹710.85 lakhs against a profit of ₹108.50 lakhs in FY25. Annual revenue from operations saw a significant decline of 27.6%, falling to ₹7347.13 lakhs from ₹10146.96 lakhs. The company also announced the appointment of M/s H D Panchal & Co as Internal Auditors for the upcoming financial year.
Key Highlights
Q4 FY26 revenue increased significantly to ₹3175.53 lakhs from ₹1673.11 lakhs YoY.
Company achieved a Q4 net profit of ₹146.49 lakhs, recovering from a loss of ₹116.20 lakhs YoY.
Full-year FY26 revenue declined to ₹7347.13 lakhs from ₹10146.96 lakhs in FY25.
FY26 ended with a total comprehensive loss of ₹704.07 lakhs.
M/s H D Panchal & Co appointed as Internal Auditor for the financial year ending March 31, 2027.
👀 What to Watch
While the Q4 recovery is a positive sign, the substantial full-year loss and revenue decline suggest underlying business volatility; investors should wait for consistent quarterly performance before increasing exposure.
Ishan Dyes Q4 Turnaround with ₹1.46 Cr Profit; FY26 Annual Revenue Down 27.6%
Ishan Dyes and Chemicals reported a strong recovery in Q4 FY26 with revenue jumping nearly 90% YoY to ₹31.76 crore and a net profit of ₹1.46 crore, compared to a loss in the previous year's quarter. Despite the quarterly recovery, the full-year FY26 performance was weak, posting a net loss of ₹7.11 crore against a profit of ₹1.08 crore in FY25. The company significantly expanded its fixed asset base to ₹163.40 crore and raised approximately ₹45 crore through equity and warrants during the year.
Key Highlights
Q4 FY26 revenue from operations rose 89.8% YoY to ₹31.76 crore from ₹16.73 crore.
Achieved a Q4 net profit of ₹1.46 crore, reversing a net loss of ₹1.16 crore in Q4 FY25.
Full-year FY26 net loss stood at ₹7.11 crore compared to a net profit of ₹1.08 crore in FY25.
Property, Plant, and Equipment surged to ₹163.40 crore from ₹61.81 crore, indicating major capacity capitalization.
Raised ₹39.92 crore via share issuance and ₹5.39 crore through warrants to bolster the balance sheet.
👀 What to Watch
Investors should monitor if the Q4 turnaround marks a sustainable trend and how the massive increase in fixed assets translates into higher operational scale in FY27.
Ishan Dyes Shareholders Approve Re-appointment of MD and WTD with 99.31% Majority
Ishan Dyes and Chemicals Limited has successfully passed two special resolutions via postal ballot for the re-appointment of its top leadership. Shareholders approved the re-appointment of Mr. Piyushbhai Natvarlal Patel as Managing Director and Mr. Shrinal P Patel as Whole Time Director. Both resolutions received overwhelming support, with 99.31% of the 1.07 crore votes cast in favor. The total voting participation represented approximately 41.03% of the company's outstanding shares.
Key Highlights
Re-appointment of Mr. Piyushbhai Natvarlal Patel as Managing Director approved with 99.31% votes in favor.
Re-appointment of Mr. Shrinal P Patel as Whole Time Director approved with 99.31% votes in favor.
Total votes polled amounted to 1,07,24,376 shares, representing 41.03% of the total shareholding.
Promoter group voted 100% in favor of both resolutions, contributing 96.43 lakh votes.
Public non-institutional shareholders cast 10.80 lakh votes, with 93.16% supporting the resolutions.
👀 What to Watch
The approval ensures leadership continuity, which is a positive sign for the company's operational stability. Investors should continue to monitor the company's financial performance under this retained management team.
Ishan Dyes Seeks Approval for Re-appointment of MD and WTD for 5-Year Terms
Ishan Dyes and Chemicals Limited has initiated a postal ballot to seek shareholder approval for the re-appointment of its top leadership. Mr. Piyushbhai Natvarlal Patel is proposed for re-appointment as Managing Director and Mr. Shrinal P Patel as Whole Time Director, both for five-year terms starting in 2026. The remuneration for both roles is capped at 5% of net profits, with minimum monthly guarantees of ₹5 lakh and ₹4 lakh respectively in case of profit inadequacy. Shareholders can cast their votes electronically between April 1 and April 30, 2026.
Key Highlights
Re-appointment of Mr. Piyushbhai Natvarlal Patel as MD for 5 years effective June 1, 2026
Re-appointment of Mr. Shrinal P Patel as Whole Time Director for 5 years effective February 1, 2026
Proposed MD remuneration includes a minimum of ₹5,00,000 per month if profits are inadequate
Proposed WTD remuneration includes a minimum of ₹4,00,000 per month if profits are inadequate
Remote e-voting period scheduled from April 1, 2026, to April 30, 2026
👀 What to Watch
Investors should evaluate the proposed remuneration against the company's historical profit margins and ensure they participate in the e-voting process before the April 30 deadline.
Ishan Dyes Allots 7.40 Lakh Equity Shares to Promoter at ₹63/Share
Ishan Dyes and Chemicals Limited has allotted 7,40,700 equity shares to its promoter, Piyushbhai Natvarlal Patel, following the exercise of convertible warrants. The shares were issued at a price of ₹63 each, resulting in a capital infusion of approximately ₹3.50 crore (representing the 75% balance payment). This allotment increases the company's total paid-up equity share capital to 2,73,04,397 shares. Currently, 34,20,892 warrants remain outstanding for conversion within the 18-month window from the original allotment date.
Key Highlights
Allotment of 7,40,700 fully paid-up equity shares at an issue price of ₹63 per share
Receipt of ₹3,49,98,075 as the 75% balance payment from the promoter allottee
Total paid-up equity capital increased from ₹26.56 crore to ₹27.30 crore
34,20,892 warrants remain outstanding for conversion out of the original 45,84,872 warrants
👀 What to Watch
The promoter's decision to convert warrants and infuse capital is a positive signal of confidence in the company's long-term value. Investors should be aware of the potential for further equity dilution as the remaining 34.21 lakh warrants are converted.
Ishan Dyes Allots 7.40 Lakh Shares to Promoter at ₹63/share via Warrant Conversion
Ishan Dyes and Chemicals has approved the allotment of 7,40,700 equity shares to promoter Piyushbhai Natvarlal Patel following the exercise of convertible warrants. The shares were issued at a price of ₹63 each, bringing in a capital infusion of approximately ₹3.5 crore (the 75% balance payment). This conversion is part of a larger preferential issue of 45.84 lakh warrants initiated in September 2025. Consequently, the company's total paid-up equity capital has increased to 2.73 crore shares.
Key Highlights
Allotment of 7,40,700 equity shares at an issue price of ₹63 per share (including ₹53 premium).
Receipt of ₹3,49,98,075 as the 75% balance payment from the promoter allottee.
Total paid-up equity share capital increased from ₹26.56 crore to ₹27.30 crore.
34,20,892 warrants remain outstanding for conversion within the 18-month window ending March 2027.
👀 What to Watch
The promoter's exercise of warrants at ₹63 per share signals confidence in the company's valuation and long-term growth. Investors should monitor the impact of further equity dilution as the remaining 34.2 lakh warrants are converted.
Ishan Dyes Allots 4.23 Lakh Shares at ₹63; Appoints New Internal Auditor
Ishan Dyes and Chemicals Limited has allotted 4,23,280 equity shares to a promoter, Anilaben Piyushbhai Patel, following the conversion of warrants at an issue price of ₹63 per share. This conversion brought in approximately ₹2 crore as the balance 75% payment, increasing the paid-up capital to ₹26.56 crore. Simultaneously, the company announced the resignation of its internal auditor, M/s K. D. Dave & Co, citing professional commitments, and appointed M/s. H D Panchal & Co. for FY 2025-26. The board is also seeking shareholder approval for the re-appointment of the Managing Director and Whole-Time Director.
Key Highlights
Allotted 4,23,280 equity shares at ₹63 each to promoter Anilaben Piyushbhai Patel.
Received ₹1,99,99,980 as the final 75% payment for the warrant conversion.
Paid-up equity share capital increased from ₹26.14 crore to ₹26.56 crore.
M/s. H D Panchal & Co. appointed as Internal Auditor following the resignation of M/s K. D. Dave & Co.
41,61,592 warrants remain outstanding for conversion within the 18-month window ending March 2027.
👀 What to Watch
The promoter's warrant conversion at ₹63 indicates confidence in the company's valuation. Investors should monitor the upcoming postal ballot for the re-appointment of top management to ensure leadership continuity.
Ishan Dyes Allots 4.23 Lakh Equity Shares to Promoter at ₹63/Share
Ishan Dyes and Chemicals has allotted 4,23,280 equity shares to a promoter, Anilaben Piyushbhai Patel, following the conversion of warrants. The shares were issued at ₹63 each, resulting in a capital infusion of approximately ₹2 crore (representing the 75% balance payment). This conversion is part of a larger preferential issue of 45.84 lakh warrants initiated in September 2025, with 41.61 lakh warrants still outstanding. Additionally, the company announced a change in its internal auditor and plans to seek shareholder approval for the re-appointment of its Managing Director and Whole-Time Director.
Key Highlights
Allotment of 4,23,280 equity shares at an issue price of ₹63 per share to the promoter group.
Receipt of ₹1,99,99,980 as the 75% balance payment for the warrant conversion.
Total paid-up equity capital increased from 2,61,40,417 to 2,65,63,697 shares.
41,61,592 warrants remain outstanding for conversion within 18 months from September 2025.
Appointment of M/s. H D Panchal & Co. as the new Internal Auditor following the resignation of M/s K. D. Dave & Co.
👀 What to Watch
Investors should view the promoter's decision to convert warrants as a positive signal of commitment and confidence in the company's valuation. Monitor the potential for further equity dilution as the remaining 41.6 lakh warrants are converted over the next year.
Ishan Dyes Allots 4.23 Lakh Shares on Warrant Conversion; Appoints New Internal Auditor
Ishan Dyes and Chemicals Limited has allotted 4,23,280 equity shares to a promoter following the conversion of warrants at an issue price of ₹63 per share. This conversion resulted in a cash inflow of approximately ₹2 crore, representing the balance 75% payment. The company also announced the resignation of its internal auditor, M/s K. D. Dave & Co., and the subsequent appointment of M/s. H D Panchal & Co. Furthermore, the board is seeking shareholder approval via postal ballot for the re-appointment of the Managing Director and Whole-Time Director.
Key Highlights
Allotted 4,23,280 equity shares to promoter Anilaben Piyushbhai Patel at ₹63 per share (including ₹53 premium).
Received ₹1,99,99,980 as the balance 75% payment for the warrant conversion.
Company's paid-up equity share capital increased from ₹26.14 crore to ₹26.56 crore post-allotment.
41,61,592 warrants remain outstanding for conversion within the 18-month window from September 2025.
Appointed M/s. H D Panchal & Co. as Internal Auditors for FY 2025-26 following a resignation.
👀 What to Watch
The promoter's decision to convert warrants and infuse capital is a positive signal of confidence in the company's long-term prospects. Investors should monitor the potential dilution from the remaining 41.6 lakh outstanding warrants.
Ishan Dyes Reports Q3 Net Loss of ₹5.25 Cr; Re-appoints MD for 5-Year Term
Ishan Dyes and Chemicals reported a weak performance for Q3 FY26, swinging to a net loss of ₹525.24 lakhs from a marginal profit of ₹4.90 lakhs in the year-ago period. Revenue from operations for the quarter fell to ₹1,868.65 lakhs, while the nine-month revenue saw a drastic decline of over 50% to ₹4,171.60 lakhs compared to ₹8,473.85 lakhs in the previous year. The company also announced the re-appointment of its founding promoter, Mr. Piyushbhai Natvarlal Patel, as Managing Director for a five-year term starting June 2026. The financial results highlight significant operational pressure with total expenses exceeding total income for the quarter.
Key Highlights
Net loss of ₹525.24 lakhs in Q3 FY26 compared to a profit of ₹4.90 lakhs in Q3 FY25.
9M FY26 revenue from operations dropped sharply to ₹4,171.60 lakhs from ₹8,473.85 lakhs in 9M FY25.
Total expenses for the quarter stood at ₹2,357.65 lakhs, significantly higher than the total income of ₹1,956.11 lakhs.
Basic and Diluted EPS for Q3 FY26 fell to -₹2.01 from ₹0.02 in the corresponding quarter last year.
Re-appointment of MD Piyushbhai Natvarlal Patel approved for a 5-year term from June 1, 2026, to May 31, 2031.
👀 What to Watch
Investors should exercise caution as the company has moved from profitability to significant losses alongside a major contraction in revenue. It is advisable to wait for management commentary on margin recovery and demand outlook before making new positions.
Ishan Dyes Commences Sulphuric Acid Production; Commercial Sales to Start Jan 31, 2026
Ishan Dyes and Chemicals has successfully operationalized its new Sulphuric Acid plant (Unit 2) as of January 23, 2026. The facility has already begun continuous supply for internal consumption to the company's existing Phthalocyanine Pigments unit (Unit 1), which should improve operational margins. Additionally, the company is set to begin commercial sales of Sulphuric Acid to external customers starting January 31, 2026. This move represents both backward integration and a new revenue stream, likely boosting overall profitability.
Key Highlights
Commenced continuous internal consumption of Sulphuric Acid from Unit 2 on January 23, 2026
Commercial sales of Sulphuric Acid to external customers to begin on January 31, 2026
New project provides backward integration for the existing Phthalocyanine Pigments Plant
Management expects the expansion to create significant synergies and a new growth trajectory for revenues
👀 What to Watch
Investors should monitor the upcoming quarterly results to quantify the margin improvement from backward integration and the revenue contribution from external acid sales. The stock may see positive re-rating as the company transitions from a single-product focus to a more integrated chemical player.
